Patents Assigned to Shape Therapeutics Inc.
  • Stable cell lines for inducible production of rAAV virions
    Patent number: 12054738
    Abstract: Described herein are polynucleotide constructs and stable cell lines for inducible production of rAAV virions within which are packaged a payload polynucleotide.
    Type: Grant
    Filed: July 30, 2021
    Date of Patent: August 6, 2024
    Assignee: Shape Therapeutics Inc.
    Inventors: Kenneth Prentice, Sandhya Pande
  • Therapeutic editing
    Patent number: 11827880
    Abstract: Disclosed herein are compositions that comprise engineered polynucleotides, pharmaceutical compositions comprising the same, methods of making the same, and methods of treatment comprising the compositions that comprise the engineered polynucleotides.
    Type: Grant
    Filed: December 1, 2020
    Date of Patent: November 28, 2023
    Assignee: Shape Therapeutics Inc.
    Inventors: David Huss, Prashant Mali, Anupama Lakshmanan, Christopher Nye, Yiannis Savva, Liana Stein, Richard Sullivan, Rafael Ponce, Susan Byrne